SCHEMBL8967206

SCHEMBL8967206

CCCCCCOCCCN1CCCCC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.56
HRH3 Q9Y5N1 7/20 0.52
SLC6A2 P23975 2/20 0.47
HRH1 P35367 2/20 0.47
CHRM2 P08172 1/20 0.47
ADRA2C P18825 1/20 0.47
SLC6A4 P31645 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KCNH2 Q12809 1/20 0.47
CACNA1C Q13936 1/20 0.47
SCN5A Q14524 1/20 0.47
THRA P10827 2/20 0.47
THRB P10828 2/20 0.47
CHRM4 P08173 1/20 0.46
HTR2C P28335 1/20 0.46
HTR7 P34969 1/20 0.46
TMEM97 Q5BJF2 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
GNAI3 P08754 3/20 0.46
GNAO1 P09471 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15510624 1.00 LTA4H (0.56) LTA4HHRH3SLC6A2HRH1CHRM2
SCHEMBL15510577 1.00 LTA4H (0.56) LTA4HHRH3SLC6A2HRH1CHRM2
SCHEMBL15510498 0.98 LTA4H (0.53) LTA4HHRH3SLC6A2HRH1CHRM2
SCHEMBL29657260 0.98 LTA4H (0.57) LTA4HHRH3SLC6A2HRH1CHRM2
SCHEMBL21348125 0.98 LTA4H (0.57) LTA4HHRH3SLC6A2HRH1CHRM2
SCHEMBL12120102 0.96 LTA4H (0.60) LTA4HHRH3SLC6A2HRH1CHRM2
SCHEMBL12120097 0.96 LTA4H (0.60) LTA4HHRH3SLC6A2HRH1CHRM2
SCHEMBL3305761 0.96 LTA4H (0.60) LTA4HHRH3SLC6A2HRH1CHRM2
SCHEMBL12120092 0.96 LTA4H (0.60) LTA4HHRH3SLC6A2HRH1CHRM2
SCHEMBL8967221 0.96 LTA4H (0.60) LTA4HHRH3SLC6A2HRH1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5348964-A Anticholesterol agents or fungicides MERRELL DOW PHARMACEUTICALS INC. (US) 1994-09-20 US claimed
US-20230399303-A1 Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same UNIV YALE (US) 2023-12-14 US disclosed
US-10336721-B2 Biaryltriazole inhibitors of macrophage migration inhibitory factor YALE UNIVERSITY (US) 2019-07-02 US disclosed
EP-2708529-B1 METHOD FOR MANUFACTURING PARTICLES SUMITOMO CHEMICAL CO (JP) 2018-04-04 EP disclosed
US-9796831-B2 Process for producing particles SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-24 US disclosed
EP-2708529-A1 METHOD FOR MANUFACTURING PARTICLES Sumitomo Chemical Company Limited (JP) 2014-03-19 EP disclosed
US-20140065337-A1 PROCESS FOR PRODUCING PARTICLES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-03-06 US disclosed
EP-0468434-B1 Novel piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis MERRELL DOW PHARMA (US) 1996-02-28 EP disclosed
US-5348964-A Anticholesterol agents or fungicides MERRELL DOW PHARMACEUTICALS INC. (US) 1994-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336721-B2 Biaryltriazole inhibitors of macrophage migration inhibitory factor MIF, MMP12, CSF1R LTA4H 1033/4885HRH3 2066/4885SLC6A2 3467/4885
US-20230399303-A1 Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same MIF, MMP12, METAP1 LTA4H 265/4885HRH3 3657/4885SLC6A2 2796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.